Find Paid Clinical Trials in South Korea

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Korea, South

Top of Directory » All Locations » More Countries » Korea, South


  • Anatomical Study Using Ultrasonography

    Condition:   Surgery
    Intervention:  
    Sponsor:   Yonsei University
    Completed - verified November 2009

  • Preemptive Low-dose Epidural Ketamine for Preventing Chronic Post-thoracotomy Pain

    Condition:   Chronic Post-thoracotomy Pain
    Interventions:   Drug: Ketamine;   Drug: ketamine free
    Sponsor:   Seoul National University Hospital
    Completed - verified November 2009

  • Umbilical Cord Serum Eye Drops

    Condition:   Recurrent Corneal Erosion
    Intervention:   Drug: Umbilical cord serum eyedrops
    Sponsor:   Chonnam National University Hospital
    Completed - verified November 2009

  • Study to Evaluate the Pharmacokinetic Characteristics of CKD-4101 (Mycophenolate Mofetil) Tablet

    Condition:   Healthy
    Interventions:   Drug: CKD-4101 tablet;   Drug: Mycophenolate Mofetil capsule
    Sponsor:   Chong Kun Dang Pharmaceutical
    Completed - verified November 2009

  • A Phase IIb 78-week Study in Patients on a Basal Insulin +/- Metformin and/or Sulfonylurea and Are Not at Goal to Add BI 10773 vs. Placebo

    Condition:   Diabetes Mellitus, Type 2
    Intervention:   Drug: BI 10773
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

    Condition:   Hepatitis B, Chronic
    Intervention:  
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

    Conditions:   Brain Ischemia;   Intracranial Hemorrhages
    Interventions:   Drug: Cilostazol;   Drug: Probucol;   Drug: Aspirin;   Drug: placebo of cilostazol;   Drug: placebo of aspirin;   Device: ankle-brachial index (ABI);   Device: intima-medial thickness (IMT);   Device: new asymptomatic brain hemorrhage;   Device: new ischemic lesions on follow-up FLAIR images
    Sponsors:   Asan Medical Center;   Korea Otsuka International Asia Arab
    Recruiting - verified November 2009

  • Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 Diabetes

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: linagliptin;   Drug: placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism

    Conditions:   Coronary Artery Disease;   Percutaneous Coronary Intervention
    Intervention:   Drug: cilostazol 100mg bid or clopidogrel 150-mg daily
    Sponsor:   Gyeongsang National University Hospital
    Completed - verified November 2009

  • Comparison of Cage Versus Plate in One Level Cervical Disc Disease

    Condition:   Cervical Disc Disease
    Intervention:  
    Sponsor:   Seoul National University Hospital
    Recruiting - verified November 2009

  • Safety Study of Autologous Cultured Adipose -Derived Stem Cells for the Fecal Incontinence

    Condition:   Fecal Incontinence
    Intervention:   Biological: ANT-SM
    Sponsor:   Anterogen Co., Ltd.
    Recruiting - verified November 2009

  • Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin

    Conditions:   Chemotherapy-Induced Nausea and Vomiting;   Ovarian Cancer
    Intervention:   Drug: Aprepitant/Ramosetron/Dexamethasone
    Sponsors:   Samsung Medical Center;   Merck
    Not yet recruiting - verified November 2009

  • Regulatory Post Marketing Surveillance Study on Nexavar®

    Conditions:   Carcinoma, Hepatocellular;   Carcinoma, Renal Cell
    Intervention:   Drug: Sorafenib ( Nexavar, BAY43-9006)
    Sponsor:   Bayer
    Recruiting - verified November 2009

  • Perioperative Iron With Erythropoietin in Bilateral Total Knee Replacement Arthroplasty (TKRA)

    Conditions:   Anemia;   Transfusion
    Interventions:   Drug: iron sucrose, erythropoietin-β;   Drug: normal saline
    Sponsor:   Seoul National University Bundang Hospital
    Recruiting - verified November 2009

  • A Study of HM10760A (Long-acting Erythropoietin (EPO)) in Healthy Korean Subjects

    Condition:   Healthy
    Intervention:   Drug: HM10760A or Placebo
    Sponsor:   Hanmi Pharmaceutical Company Limited
    Recruiting - verified November 2009

  • Safety and Efficacy Study of Autologous Cultured Adipose -Derived Stem Cells for the Crohn's Fistula

    Condition:   Crohn's Fistula
    Intervention:   Drug: ADIPOPLUS
    Sponsor:   Anterogen Co., Ltd.
    Not yet recruiting - verified November 2009

  • Different Metabolic Effects of Statins

    Condition:   Hypercholesterolemia
    Intervention:   Drug: pravastatin, rosuvastatin
    Sponsor:   Gachon University Gil Medical Center
    Recruiting - verified November 2009

  • Metagenomic Analysis of Gut Microbiome in Korean Patients With Ulcerative Colitis

    Condition:   Ulcerative Colitis
    Interventions:   Procedure: Colonoscopy biopsy;   Other: stool collection;   Procedure: colonoscopy biopsy;   Other: stool collection
    Sponsors:   Seoul National University Hospital;   Korea Food and Drug Administration
    Recruiting - verified November 2009

  • Cervical Epidural Pressure Measurement

    Conditions:   Head Pain;   Neck Pain;   Upper Extremity Pain
    Interventions:   Procedure: cervical epidural steroid injection;   Procedure: epidural pressure measurement
    Sponsor:   Seoul National University Bundang Hospital
    Enrolling by invitation - verified November 2009

  • Efficacy and Safety of CDP-choline in Patients With Methamphetamine Dependence

    Condition:   Methamphetamine Dependence
    Interventions:   Dietary Supplement: CDP-choline;   Dietary Supplement: Placebo (fructose)
    Sponsor:   Seoul National University Hospital
    Not yet recruiting - verified November 2009

  • Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress Disorder

    Condition:   Posttraumatic Stress Disorder
    Intervention:   Drug: escitalopram (lexapro)
    Sponsor:   Seoul National University Hospital
    Recruiting - verified November 2009

  • Safety and Efficacy Study of Single Port Laparoscopic Appendectomy in Acute Appendicitis

    Condition:   Appendicitis
    Interventions:   Procedure: Single port laparoscopic appendectomy;   Procedure: 3 port laparoscopic appendectomy
    Sponsor:   Kyunghee University Medical Center
    Not yet recruiting - verified November 2009

  • Effect of Dexamethasone Combined With Ondansetron on Postoperative Nausea and Vomiting in Patients With Patient-controlled Analgesia After Video-assisted Thoracoscopic Surgery

    Conditions:   Nausea;   Vomiting
    Intervention:   Drug: Dexamethasone, Ondansetron
    Sponsor:   Yonsei University
    Recruiting - verified November 2009

  • Pharmacokinetics/Pharmacodynamics (PK/PD) Characteristics of Tolvaptan Tablet in Korean Healthy Male

    Condition:   Healthy
    Intervention:   Drug: Tolvaptan 15mg or 30mg or 60mg or Placebo
    Sponsor:   Korea Otsuka Pharmaceutical Co.,Ltd.
    Not yet recruiting - verified November 2009

  • Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH4808 After Oral Administration in Healthy Male Subjects

    Condition:   Healthy
    Interventions:   Drug: YH4808;   Drug: YH4808;   Drug: YH4808;   Drug: YH4808;   Drug: YH4808;   Drug: YH4808;   Drug: YH4808;   Drug: YH4808
    Sponsor:   Yuhan Corporation
    Not yet recruiting - verified November 2009

  • Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma Assay

    Condition:   Latent Tuberculosis Infection
    Intervention:  
    Sponsor:   Samsung Medical Center
    Recruiting - verified November 2009

  • Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma

    Condition:   Stage I/II Extranodal NK/T-cell Lymphoma
    Intervention:   Other: concomitant chemo-radiotherapy followed by VIDL chemotherapy with risk-based application of autologous stem cell transplantation
    Sponsors:   Samsung Medical Center;   Asan Medical Center;   National Cancer Center, Korea;   Severance Hospital
    Recruiting - verified November 2009

  • Postoperative Pain After Volar Plating for Distal Radius Fractures

    Condition:   Distal Radius Fractures
    Intervention:   Procedure: periarticular anesthetics injection
    Sponsors:   Seoul National University Hospital;   Seoul National University Bundang Hospital
    Completed - verified November 2009

  • Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

    Condition:   Retinal Vein Occlusion
    Interventions:   Drug: VEGF Trap-Eye (BAY86-5321);   Other: Sham treatment
    Sponsors:   Bayer;   Regeneron Pharmaceuticals
    Recruiting - verified November 2009

  • A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Glycopyrronium bromide;   Drug: Placebo
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • First-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALL

    Condition:   Acute Lymphoblastic Leukemia
    Interventions:   Drug: Dasatinib;   Drug: Cyclophosphamide;   Drug: Vincristine;   Drug: Daunorubicin;   Drug: Dexamethasone;   Drug: Cytarabine;   Drug: Mitoxantrone
    Sponsor:   The Catholic University of Korea
    Not yet recruiting - verified October 2009

  • An Investigator-blind Multi-center Prospective Study for the Efficacy and Safety of Silicon Gel (Dermatix)

    Condition:   Hypertrophic Cicatrix
    Interventions:   Device: silicone gel;   Other: no treatment
    Sponsors:   Samsung Medical Center;   Seoul National University Hospital;   Kyunghee University Medical Center;   Inovail
    Not yet recruiting - verified October 2009

  • BIBW 2992 as a Third-line Treatment for Patients With Stage IIIB/IV Adenocarcinoma of the Lung Harbouring Wild-type Epidermal Growth Factor Receptor [EGFR]

    Condition:   Carcinoma, Non-Small-Cell Lung
    Intervention:   Drug: BIBW 2992
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Not yet recruiting - verified October 2009

  • Differential Metabolic Effects of Fenofibrate and Fatty Acid

    Condition:   Hypertriglyceridemia
    Intervention:  
    Sponsor:   Gachon University Gil Medical Center
    Recruiting - verified October 2009

  • Additive Effects of Pravastatin and Valsartan

    Conditions:   Hypertension;   High Cholesterol
    Intervention:  
    Sponsor:   Gachon University Gil Medical Center
    Recruiting - verified November 2009

  • Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV

    Condition:   Non Small Cell Lung Cancer
    Intervention:   Drug: Irinotecan, Cisplatin, Gemcitabine, Pemetrexed, Docetaxel
    Sponsor:   National Cancer Center, Korea
    Recruiting - verified October 2009

  • Hemodynamic Changes of Upper and Lower Extremities After Spinal Anesthesia

    Condition:   Hypertension
    Intervention:   Procedure: spinal anesthesia for surgery
    Sponsor:   Yonsei University
    Not yet recruiting - verified October 2009

  • Effect of the Bevel Direction of Puncture Needle on Success Rate and Complications During Central Venous Catheterization

    Condition:   Central Venous Catheterization
    Interventions:   Device: bevel direction during central venous catheterization;   Device: bevel direction during central venous catheterization
    Sponsor:   Seoul National University Hospital
    Recruiting - verified October 2009

  • Effects of Acupuncture at ST36 and PC6 on Blood Pressure and Endothelial Dysfunction in Hypertensive Patients

    Condition:   Hypertension
    Intervention:   Procedure: acupuncture
    Sponsor:   Kyunghee University Medical Center
    Recruiting - verified October 2009

  • Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer

    Condition:   Gastric Cancer
    Interventions:   Drug: Helicobacter pylori eradication;   Drug: placebo
    Sponsor:   National Cancer Center, Korea
    Completed - verified October 2009

  • Vanguard Complete Knee Versus Vanguard High Flex Rotating Platform (RP) Knee Study

    Conditions:   Osteoarthritis;   Rheumatoid Arthritis;   Traumatic Arthritis
    Interventions:   Device: Vanguard Complete Knee System w/ std tray;   Device: Vanguard High Flex RP
    Sponsor:   Biomet, Inc.
    Recruiting - verified November 2009

  • An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: CKD-501 0.5mg;   Drug: Placebo
    Sponsor:   Chong Kun Dang Pharmaceutical
    Recruiting - verified October 2009

  • Effect of Nafamostat on Postreperfusion Syndrome

    Conditions:   Liver Transplantation;   Postreperfusion Syndrome
    Interventions:   Drug: Nafamostat;   Drug: Normal saline
    Sponsor:   Seoul National University Hospital
    Recruiting - verified October 2009

  • Reduction of Remifentanil-related Complications by Limiting Maximum Plasma Concentration During Target-controlled Infusion

    Condition:   Anesthesia
    Interventions:   Drug: Remifentanil (Limited) - Target Controlled Infusion system;   Drug: Remifentanil (Control) - Target Controlled Infusion system
    Sponsor:   Seoul National University Hospital
    Not yet recruiting - verified October 2009

  • The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer

    Conditions:   Erlotinib;   Lung Cancer
    Intervention:  
    Sponsor:   Asan Medical Center
    Recruiting - verified October 2009

  • Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male Subjects

    Condition:   Healthy
    Intervention:   Drug: LC15-0444, Pioglitazone
    Sponsor:   LG Life Sciences
    Recruiting - verified October 2009

    • Menu
    Find Paid Clinical Trials